Page 23 - ATP-P 11th Ed

g. Pre-stage an insulated hypothermia enclosure system with external active heating
for transition from the non-insulated hypothermia enclosure systems; seek to im-
prove upon existing enclosure system when possible.
h. Use a battery-powered warming device to deliver IV/IO resuscitation fluids, in ac- SECTION 1
cordance with current CoTCCC guidelines, at flow rate up to 150 ml/min with a
38°C output temperature.
i. Protect the casualty from exposure to wind and precipitation on any evacuation
platform.
8. Penetrating Eye Trauma
a. If a penetrating eye injury is noted or suspected:
i. Perform a rapid field test of visual acuity and document findings.
ii. Cover the eye with a rigid eye shield (NOT a pressure patch.)
iii. Ensure that the 400mg moxifloxacin tablet in the Combat Wound Medication
Pack (CWMP) is taken if possible and that IV/IM antibiotics are given as
outlined below if oral moxifloxacin cannot be taken.
9. Monitoring
a. Initiate advanced electronic monitoring if indicated and if monitoring equipment is
available.
10. Analgesia
a. TCCC non-medical first responders should provide analgesia on the battlefield
achieved by using:
i. Mild to Moderate Pain
ii. Casualty is still able to fight
(a) TCCC Combat Wound Medication Pack (CWMP)
• Acetaminophen – 500mg tablet, 2 PO q8hr
• Meloxicam – 15mg PO once a day
b. TCCC Medical Personnel:
Option 1
i. Mild to Moderate Pain
ii. Casualty is still able to fight
(a) TCCC Combat Wound Medication Pack (CWMP)
• Acetaminophen – 500mg tablet, 2 PO q8hr
• Meloxicam – 15mg PO once a day
Option 2
i. Mild to Moderate Pain
ii. Casualty IS NOT in shock or respiratory distress AND Casualty IS NOT at
significant risk of developing either condition.
(a) Oral transmucosal fentanyl citrate (OTFC) 800μg
• May repeat once more after 15 minutes if pain uncontrolled by first

12 SECTION 1 TACTICAL TRAUMA PROTOCOLS (TTPs) ATP-P Handbook 11th Edition 13